Back

Diabetes: how to reduce risk from a cardiovascular perspective?

19 April 2018 (13:05 - 13:20)
Organised by:
Congress Presentation Part of: Preventing cardiovascular disease in patients with T2DM: how to apply novel outcome data with GLP-1 ra to clinical practice. Diabetes and the Heart EAPC Premium Access EuroPrevent 2018

About the speaker

Photo
Professor Diederick E Grobbee

University Medical Center Utrecht, Utrecht (Netherlands (The))

4 More presentations in this session

Presentation thumbnail
Introduction - Preventing cardiovascular disease in patients with T2DM: how to apply novel outcome data with GLP-1 ra to clinical practice.
Professor D. Grobbee (Utrecht, NL)
Slides Video
Presentation thumbnail
The cardiovascular challenge for primary care in diabetes.
Professor R. Hobbs (Oxford, GB)
Slides Video
Presentation thumbnail
Practical management of cardiovascular risk: lessons from latest diabetes trials.
Professor L. Ryden (Stockholm, SE)
Slides Video
Presentation thumbnail
Discussion - Preventing cardiovascular disease in patients with T2DM: how to apply novel outcome data with GLP-1 ra to clinical practice.
Professor R. Hobbs (Oxford, GB) Professor D. Grobbee (Utrecht, NL) Professor L. Ryden (Stockholm, SE)
Slides Video

Access the full session

Session thumbnail
Preventing cardiovascular disease in patients with T2DM: how to apply novel outcome data with GLP-1 ra to clinical practice.

The Event

Event poster

EuroPrevent 2018

19 April 2018 13:05 CET
You may be interested in
thumbnail
Webinar
EAPC Webinar: Type 2 Diabetes and cardiovascular risk
12 March 2019
thumbnail
Congress Presentation
Glucose lowering drugs or strategies, major adverse cardiovascular events and heart failure outcomes, and association with weight loss - meta-analysis of large cardiovascular outcome trials
2 September 2019
thumbnail
Congress Presentation
Reducing cardiovascular risk with an innovative solution mixing digital and human interventions
14 June 2025
thumbnail
Congress Presentation
Medical treatment in prediabetes to reduce CV risk and avoid transitioning to diabetes - What is the optimal choice?
26 August 2022

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources